N/A
Completed N=40
fMRI Cholinergic Mechanisms in Schizophrenia
Source: ClinicalTrials.gov NCT01191827 ↗Enrolled (actual)
40
Serious AEs
—
Results posted
May 2015
Primary outcomePrimary: Neuronal Response During Sensory Gating — .12; .11 % BOLD signal
Summary
This study aims to determine how clozapine treatment improves neuronal measures of sensory gating in subjects with schizophrenia.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Neuronal Response During Sensory Gating |
.12; .11 | — |
Eligibility Criteria
Inclusion Criteria
- Diagnosis of schizophrenia
- age 18-60 yrs
Exclusion Criteria
- claustrophobia
- weight > 250 lbs
- metal in body other than dental fillings
Data sourced from ClinicalTrials.gov (NCT01191827). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.